Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Cellectis S.A. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −6 vs. Q1 2022
- Shares held
- 10.8M
- −1.44M (−11.7%) vs. Q1 2022
- Total value
- $30.6M
- −$25.1M (−45.1%) vs. Q1 2022
- New holders
- 5
- 11 more added
- Sold out
- 11
- 19 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.6M |
| Q4 2023 | 34 | $30.5M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.7M |
| Q1 2022 | 51 | $56.4M |
| Q4 2021 | 57 | $126.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $252.6M |
| Q1 2021 | 81 | $309.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 2,791,610 | $7.90M | 1.59% | +249,251+9.8% | Added |
| Credit Suisse AG | 1,438,255 | $4.07M | 0.00% | −3,330−0.2% | Reduced |
| Principal Financial Group Inc | 1,348,312 | $3.82M | 0.00% | +133,587+11.0% | Added |
| Baillie Gifford & Co | 880,932 | $2.49M | 0.00% | −201,163−18.6% | Reduced |
| Capital International Investors | 581,037 | $1.64M | 0.00% | −1,011,017−63.5% | Reduced |
| Jane Street Group, LLC | 490,230 | $1.36M | 0.00% | −113,023−18.7% | Reduced |
| Millennium Management LLC | 452,941 | $1.28M | 0.00% | +50,039+12.4% | Added |
| Bpifrance SA | 425,726 | $1.21M | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 290,025 | $821.0K | 0.00% | −12,484−4.1% | Reduced |
| Hudson Bay Capital Management LP | 275,000 | $778.0K | 0.01% | +63,500+30.0% | Added |
| D. E. Shaw & Co., Inc. | 271,549 | $768.0K | 0.00% | −28,138−9.4% | Reduced |
| State Street Corp | 253,725 | $718.0K | 0.00% | +134,164+112.2% | Added |
| Capital World Investors | 250,000 | $708.0K | 0.00% | −371,065−59.7% | Reduced |
| Macquarie Group Ltd | 226,875 | $642.0K | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 186,018 | $526.0K | 0.00% | +43,677+30.7% | Added |
| KBC Group NV | 163,447 | $463.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 114,441 | $324.0K | 0.00% | −31,757−21.7% | Reduced |
| Morgan Stanley | 99,951 | $283.0K | 0.00% | +17,541+21.3% | Added |
| Oppenheimer & Co Inc | 75,633 | $214.0K | 0.00% | +979+1.3% | Added |
| WS Management LLLP | 50,907 | $144.0K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 23,589 | $67.0K | 0.00% | +23,589 | New |
| Bank of America Corp | 21,816 | $61.0K | 0.00% | −21,799−50.0% | Reduced |
| Envestnet Asset Management Inc | 20,939 | $59.0K | 0.00% | +438+2.1% | Added |
| Virtu Financial LLC | 16,366 | $46.0K | 0.00% | +16,366 | New |
| Two Sigma Advisers, LP | 15,300 | $43.0K | 0.00% | −39,500−72.1% | Reduced |
| Vontobel Holding Ltd. | 14,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11,829 | $33.0K | 0.00% | −1,100−8.5% | Reduced |
| Princeton Capital Management LLC | 10,594 | $30.0K | 0.01% | −335−3.1% | Reduced |
| Geode Capital Management, LLC | 10,776 | $30.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,803 | $19.0K | 0.00% | −87−1.3% | Reduced |
| Tower Research Capital LLC (TRC) | 6,363 | $18.0K | 0.00% | −1,886−22.9% | Reduced |
| National Bank of Canada | 3,600 | $10.0K | 0.00% | +3,600 | New |
| JPMorgan Chase & Co | 943 | $3.00K | 0.00% | −1,466−60.9% | Reduced |
| Assetmark, Inc | 865 | $2.00K | 0.00% | +505+140.3% | Added |
| Citigroup Inc | 324 | $1.00K | 0.00% | −35,424−99.1% | Reduced |
| UBS Group AG | 394 | $1.00K | 0.00% | −2,374−85.8% | Reduced |
| TD Waterhouse Canada Inc. | 360 | $954 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 229 | $648 | 0.00% | +229 | New |
| US Bancorp | 10 | $0 | 0.00% | −1,984−99.5% | Reduced |
| Parkside Financial Bank & Trust | 147 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 108 | $0 | 0.00% | +18+20.0% | Added |
| Daiwa Securities Group Inc. | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $0 | 0.00% | +31 | New |
| Sofos Investments, Inc. | 12 | – | – | −8−40.0% | Reduced |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −131,848−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −53,223−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −38,455−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −33,595−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −17,696−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −17,068−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,036−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −325−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |